![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1401924
¼¼°èÀÇ ½º¸¶Æ® ÄÜÅÃÆ®·»Áî ½ÃÀå ¿¹Ãø(-2030³â) : À¯Çüº°, ¼ÒÀ纰, »ç¿ë¼ºº°, Àα¸ À¯Çüº°, À¯Åë ä³Îº°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®Smart Contact Lenses Market Forecasts to 2030 - Global Analysis By Type, By Material (Poly, Polyvinyl Alcohol and Other Materials), By Usability, Population Type, Distribution Channel, Technology, Application, End User and By Geography |
Stratistics MRC¿¡ µû¸£¸é ½º¸¶Æ® ÄÜÅÃÆ®·»Áî ¼¼°è ½ÃÀåÀº 2023³â 71¾ï ´Þ·¯·Î ¿¹Ãø ±â°£ µ¿¾È 11.8%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 156¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
½º¸¶Æ® ÄÜÅÃÆ®·»Áî´Â ±âÁ¸ ÄÜÅÃÆ®·»Áî¿¡ ±â¼úÀ» ÅëÇÕÇÑ Ã·´Ü ¿þ¾î·¯ºí ±â±âÀÔ´Ï´Ù. °Ç° ÁöÇ¥¸¦ ¸ð´ÏÅ͸µÇϰí, Æ÷µµ´ç ¼öÄ¡¸¦ ÃøÁ¤Çϰí, Áõ°Çö½Ç °æÇèÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ºñħ½ÀÀûÀ̱⠶§¹®¿¡ Áö¼ÓÀûÀÎ °Ç° ¸ð´ÏÅ͸µ°ú ¿øÈ°ÇÑ ÅëÇÕ¿¡ Æí¸®ÇÕ´Ï´Ù.
Peter Ivins Eye Care¿¡ µû¸£¸é, 2³â°£ÀÇ ÀÓ»ó½ÃÇè °á°ú, ¹Ì¿ä½º¸¶Æ® ·»Áî´Â ±Ù½Ã ÁøÇàÀ» 59% ´ÊÃß°í Ãà¾È ¼ºÀåÀ» Æò±Õ 60% Áö¿¬½ÃŰ´Â °ÍÀ¸·Î ³ªÅ¸³µ´Ù°í ÇÕ´Ï´Ù.
Áö¼ÓÀûÀÎ °Ç° ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡
Çõ½ÅÀûÀÎ ÀåÄ¡´Â ½Ç½Ã°£ °Ç° ÀλçÀÌÆ®¸¦ ¿øÇÏ´Â °³Àο¡°Ô ºÎ´ã½º·´Áö ¾ÊÀ¸¸é¼µµ Æí¸®ÇÑ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ½º¸¶Æ® ÄÜÅÃÆ®·»Áî´Â Áß¿äÇÑ °Ç° ÁöÇ¥¸¦ ¿øÈ°ÇÏ°Ô ¸ð´ÏÅ͸µÇÏ¿© »ç¿ëÀÚ¿Í ÀÇ·á Àü¹®°¡°¡ ¸¸¼º ÁúȯÀ» °ü¸®Çϰí, ÀÌ»óÀ» °¨ÁöÇϰí, ¿¹¹æÀû ÀÇ·á ¼ºñ½º¸¦ ¹ÞÀ» ¼ö ÀÖµµ·Ï ±ÍÁßÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÕ´Ï´Ù. ¸¸¼º ÁúȯÀÇ È®»ê°ú °í·ÉÈ ½Ã´ë¿¡ Áö¼ÓÀûÀÎ °Ç° ¸ð´ÏÅ͸µÀÌ °¡´ÉÇÑ ½º¸¶Æ® ÄÜÅÃÆ®·»Áî´Â Çö´ë ÀÇ·áÀÇ ÁøÈÇÏ´Â ¿ä±¸¿¡ ºÎÀÀÇÏ°í °Ç°¿¡ ´ëÇÑ Àû±ØÀûÀÎ Á¢±ÙÀ» ÃËÁøÇÏ´Â Çõ½ÅÀû ±â¼ú·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.
Ãʱâ ÅõÀÚ ¹× À¯Áöº¸¼ö ºñ¿ë
ÀÌ·¯ÇÑ Ã·´Ü ±â¼ú ÀåÄ¡ÀÇ °³¹ß ¹× »ý»ê¿¡´Â ¿¬±¸, ¼³°è, Á¦Á¶¿¡ ¸¹Àº Ãʱ⠺ñ¿ëÀÌ ¼Ò¿äµË´Ï´Ù. ÷´Ü ¼¾¼ ±â¼ú°ú ³ª³ë ¼ÒÀ縦 µµÀÔÇϸé Á¦Á¶ ºñ¿ëÀº ´õ¿í ³ô¾ÆÁý´Ï´Ù. ¶ÇÇÑ, ½º¸¶Æ® ÄÜÅÃÆ®·»Áî¿¡ ³»ÀåµÈ ±â¼úÀÇ º¹À⼺À¸·Î ÀÎÇØ »ç¿ëÀÚ´Â Ãʱ⠱¸¸Å °¡°ÝÀÌ ³ô¾ÆÁú ¼ö ÀÖ½À´Ï´Ù. ¼ÒÇÁÆ®¿þ¾î ¾÷µ¥ÀÌÆ®, ¼ö¸® ¹× ±³Ã¼¸¦ Æ÷ÇÔÇÑ À¯Áöº¸¼ö ºñ¿ëÀº ¼ÒºñÀÚ¿Í ÀÇ·á ½Ã½ºÅÛ ¸ðµÎ¿¡ Àü¹ÝÀûÀÎ °æÁ¦Àû ºÎ´ãÀ» °¡Áß½ÃŰ´Â ¿äÀÎÀÔ´Ï´Ù. ÀÌ·¯ÇÑ °æÁ¦Àû À庮Àº ƯÈ÷ ÀÇ·á ¿¹»êÀÌ Á¦ÇÑÀûÀÌ°í °¡Ã³ºÐ ¼ÒµæÀÌ Á¦ÇÑµÈ Áö¿ª¿¡¼´Â º¸±ÞÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù.
¼¾¼ ¹× ³ª³ë±â¼úÀÇ ¹ßÀü
ÀÌ·¯ÇÑ °³¹ß·Î ½º¸¶Æ® ÄÜÅÃÆ®·»ÁîÀÇ ÄÄÆÑÆ®ÇÑ µðÀÚÀο¡ ÷´Ü ¼¾¼¿Í ¼ÒÇü ºÎǰÀ» ÅëÇÕÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. Çâ»óµÈ ¼¾¼ ±â´ÉÀº Æ÷µµ´ç ¼öÄ¡ ÃøÁ¤, ¹ÙÀÌ¿À¸¶Ä¿ °¨Áö µî º¸´Ù Á¤È®ÇÏ°í ´Ù¾çÇÑ °Ç° ¸ð´ÏÅ͸µ ±â´ÉÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ³ª³ë±â¼úÀº ´õ ÀÛ°í È¿À²ÀûÀÎ ºÎǰ Á¦ÀÛÀ» ¿ëÀÌÇÏ°Ô ÇÏ¿© ´õ¿í ½º¸¶Æ®ÇÏ°í Æí¾ÈÇÑ ½º¸¶Æ® ·»Áî °³¹ß¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áö¼ÓÀûÀÎ ±â¼ú Çõ½ÅÀº Àû¿ë ¹üÀ§¸¦ ³ÐÈú »Ó¸¸ ¾Æ´Ï¶ó Àü¹ÝÀûÀÎ ¼º´ÉÀ» Çâ»ó½Ã۰í Á¡Á¡ ´õ Á¤±³ÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ½º¸¶Æ® ÄÜÅÃÆ®·»Áî ¼Ö·ç¼ÇÀ» Á¦°øÇÒ ¼ö ÀÖ´Â ½ÃÀå ÀáÀç·ÂÀ» Ű¿ì°í ÀÖ½À´Ï´Ù.
´« °Ç° ¹× °¨¿°¿¡ ´ëÇÑ ¿ì·Á
ÀÌ·¯ÇÑ Çõ½ÅÀûÀÎ ·»Áî´Â ȹ±âÀûÀÎ ±â´ÉÀ» Á¦°øÇÏÁö¸¸ »ç¿ëÀÚ¿Í ÀÇ·á Àü¹®°¡µéÀº ´« °Ç°¿¡ ¹ÌÄ¡´Â Àå±âÀûÀÎ ¿µÇâ¿¡ ´ëÇØ ¿ì·Á¸¦ Ç¥¸íÇϰí ÀÖ½À´Ï´Ù. Àå½Ã°£ »ç¿ëÇÏ¸é ºÒÆíÇÔ, °ÇÁ¶ÇÔ, ÀÚ±ØÀ» À¯¹ßÇÒ ¼ö ÀÖ¾î ½º¸¶Æ® ÄÜÅÃÆ®·»ÁîÀÇ Àü¹ÝÀûÀÎ ¾ÈÀü¼º¿¡ Àǹ®À» Á¦±âÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ·»ÁîÀÇ ºÎÀûÀýÇÑ À§»ý »óÅÂ¿Í ¹ÐÆó¼º ÀúÇÏ¿Í °°Àº ¿äÀÎÀ¸·Î ÀÎÇÑ °¨¿°ÀÇ À§ÇèÀº ÀÌ·¯ÇÑ ¿ì·Á¸¦ ÁõÆø½Ãŵ´Ï´Ù. ´«ÀÇ ¼¶¼¼ÇÑ Æ¯¼ºÀ¸·Î ÀÎÇØ ¾ÈÀü ±âÁØ¿¡ ´ëÇÑ ¼¼½ÉÇÑ ÁÖÀǰ¡ ÇÊ¿äÇÕ´Ï´Ù.
COVID-19 »çÅ´ ½ÃÀå¿¡ ´Ù¾çÇÑ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ¿ø°Ý °Ç° ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ ¿þ¾î·¯ºí ±â¼ú¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁø ¹Ý¸é, °æÁ¦ ºÒÈ®½Ç¼º°ú °ø±Þ¸Á È¥¶õÀÌ µµÀüÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¿¬±¸°³¹ßÀÇ Áö¿¬Àº ¼ÒºñÀÚÀÇ ¿ì¼±¼øÀ§ º¯È¿Í ÇÔ²² ½ÃÀå ¿ªÇп¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ±×·¯³ª °Ç° ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ÀνÄÀÇ Áõ°¡¿Í Àü¿°º´À¸·ÎºÎÅÍÀÇ ¿Ï¸¸ÇÑ È¸º¹Àº »ç¶÷µéÀÌ COVID-19 ÀÌÈÄ ½Ã´ë¿¡ Áö¼ÓÀûÀÎ ÀǷḦ À§ÇÑ Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀ» ã°Ô µÇ¸é¼ ½ÃÀå ȸº¹¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Áø´Ü ¼¾¼ ÀÏüÇü ÄÜÅÃÆ®·»Áî°¡ ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»ó
Áø´Ü ¼¾¼°¡ ÅëÇÕµÈ ÄÜÅÃÆ®·»Áî ºÎ¹®Àº À¯¸®ÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ·»Áî¿¡´Â Æ÷µµ´ç ¼öÄ¡, ¾È¾Ð µî ´Ù¾çÇÑ °Ç° ÁöÇ¥¸¦ ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Â °í±Þ Áø´Ü ¼¾¼°¡ ³»ÀåµÇ¾î ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼¾¼°¡ ¼öÁýÇÑ ½Ç½Ã°£ µ¥ÀÌÅÍ´Â »ç¿ëÀÚ¿Í ÀÇ·á Àü¹®°¡ ¸ðµÎ¿¡°Ô ±ÍÁßÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇϰí Áö¼ÓÀûÀÎ °Ç° ¸ð´ÏÅ͸µÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ´ë»ó ±â´ÉÀº ½º¸¶Æ® ÄÜÅÃÆ®·»ÁîÀÇ Áø´Ü ¹× ¿¹¹æ Ãø¸éÀ» °ÈÇÏ¿© ÀÇ·á ±â¼ú ¹× °³ÀÎ ¸ÂÃãÇü ȯÀÚ Ä¡·áÀÇ ÁøÈ¿¡ Áß¿äÇÑ ¿ä¼Ò·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.
Æú¸®(2-ÇÏÀ̵å·Ï½Ã¿¡Æ¿ ¸ÞŸũ¸±·¹ÀÌÆ®(PHEMA) ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
Æú¸®(2-ÇÏÀ̵å·Ï½Ã¿¡Æ¿¸ÞŸũ¸±·¹ÀÌÆ®(PHEMA) ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, PHEMA´Â »ýü ÀûÇÕ¼º, ±¤ÇÐ Åõ¸í¼º, ¼öºÐ Èí¼ö·Î ¾Ë·ÁÁø ÇÏÀ̵å·Î°Ö·Î Àå½Ã°£ Âø¿ë¿¡ ÀûÇÕÇϸç, PHEMA´Â ¼¾¼ ¹× ÀüÀÚ±â±â µî ´Ù¾çÇÑ ±â¼úÀ» ÄÜÅÃÆ®·»Áî¿¡ ÅëÇÕÇÒ ¼ö ÀÖ´Â Æí¾ÈÇϰí Åë±â¼º ÀÖ´Â Ç÷§ÆûÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ¼ÒÀçÀÇ Æ¯¼ºÀ¸·Î ÀÎÇØ °Ç° ¸ð´ÏÅ͸µ ¹× Áõ°Çö½Ç(AR) ¾ÖÇø®ÄÉÀ̼ÇÀÇ °í±Þ ±â´ÉÀ» Áö¿øÇÏ¸é¼ Áö¼ÓÀûÀÌ°í Æí¾ÈÇÑ Âø¿ë°¨À» Á¦°øÇÏ´Â ½º¸¶Æ® ÄÜÅÃÆ®·»Áî °³¹ß¿¡ ÀÚÁÖ ¼±Åõǰí ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì ½º¸¶Æ® ÄÜÅÃÆ®·»Áî ½ÃÀåÀÌ ½ÃÀå Á¡À¯À²ÀÇ ´ëºÎºÐÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ Áö¿ªÀÇ ³ôÀº ÀÇ·á ÀÎÇÁ¶ó¿Í ³ôÀº ±â¼ú µµÀÔ ¼öÁØÀº ½º¸¶Æ® ÄÜÅÃÆ®·»Áî º¸±Þ¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. °Ç° ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÁÖ¿ä ½ÃÀå ÁøÀÔ ±â¾÷ ¹× ¿¬±¸ ±â°üÀÇ Á¸Àç·Î ÀÎÇØ ºÏ¹Ì´Â ½º¸¶Æ® ÄÜÅÃÆ®·»Áî °³¹ßÀÇ ÃÖÀü¼±¿¡ ¼°Ô µÇ¾ú½À´Ï´Ù. ÀÌ Áö¿ª ½ÃÀåÀº Áö¼ÓÀûÀÎ ¹ßÀü°ú °³ÀÎ ¸ÂÃãÇü ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ ¿ªµ¿ÀûÀÎ »óȲÀ¸·Î ¹ßÀüÇϰí ÀÖ½À´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾çÀº ±Þ°ÝÇÑ ½ÃÀå ¼ºÀåÀ» ¸ñ°ÝÇϰí ÀÖ½À´Ï´Ù. Àα¸ÀÇ ±ÞÁõ, ÀÇ·á¿¡ ´ëÇÑ ÀνÄÀÇ Áõ°¡, Çõ½ÅÀûÀÎ ¿þ¾î·¯ºí¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µîÀÇ ¿äÀÎÀÌ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀϺ»°ú Çѱ¹°ú °°Àº ±¹°¡µéÀº ±â¼ú ¹ßÀüÀÇ ÃÖÀü¼±¿¡ ¼¼ ½º¸¶Æ® ÄÜÅÃÆ®·»Áî °³¹ß¿¡ µµ¿òÀÌ µÇ´Â ȯ°æÀ» Á¶¼ºÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á Çõ½Å°ú »îÀÇ Áú Çâ»ó¿¡ ÁßÁ¡À» µÐ ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½º¸¶Æ® ÄÜÅÃÆ®·»Áî ½ÃÀåÀº Å« ¹ßÀü°ú ½ÃÀå ħÅõ¸¦ À§ÇÑ Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.
According to Stratistics MRC, the Global Smart Contact Lenses Market is accounted for $7.1 billion in 2023 and is expected to reach $15.6 billion by 2030 growing at a CAGR of 11.8% during the forecast period. Smart contact lenses are advanced wearable devices that integrate technology into traditional contact lenses. They can monitor health metrics, measure glucose levels and offer augmented reality experiences. Their non-intrusive nature makes them convenient for continuous health monitoring and seamless integration.
According to Peter Ivins Eye Care, 2-year clinical trial results show that MiyoSmart lenses slow myopia progression by 59% and slow axial eye growth by an average of 60%.
Rising demand for continuous health monitoring
Innovative devices offer a non-intrusive and convenient solution for individuals seeking real-time health insights. Smart contact lenses enable the seamless monitoring of vital health metrics, providing users and healthcare professionals with valuable data to manage chronic conditions, detect anomalies, and ensure proactive healthcare. With the increasing prevalence of chronic diseases and a growing aging population, the ability of smart contact lenses to offer continuous health monitoring positions them as a transformative technology, addressing the evolving needs of modern healthcare and fostering a proactive approach to well-being.
Initial investment and maintenance expenses
The development and production of these advanced technological devices involve significant upfront costs in research, design and manufacturing. The incorporation of cutting-edge sensor technologies and nanomaterials adds to the production expenses. Additionally, users may encounter higher initial purchase prices due to the complexity of the technology embedded in smart contact lenses. Maintenance costs, including software updates, repairs and replacements contribute to the overall financial burden for both consumers and healthcare systems. This financial barrier can limit widespread adoption, particularly in regions with constrained healthcare budgets and populations with limited disposable income.
Ongoing developments in sensor and nanotechnology
These developments allow for the integration of sophisticated sensors and miniature components into the compact design of smart contact lenses. Enhanced sensor capabilities enable more accurate and diverse health monitoring functionalities, such as measuring glucose levels and detecting biomarkers. Nanotechnology facilitates the creation of smaller, more efficient components, contributing to the development of sleeker and more comfortable smart lenses. This ongoing innovation not only expands the range of applications but also improves the overall performance, fostering the market's potential to deliver increasingly sophisticated and reliable smart contact lens solutions.
Concerns about eye health and potential infections
These innovative lenses offer groundbreaking capabilities, users and healthcare professionals express apprehensions about their long-term impact on ocular health. Prolonged use may lead to discomfort, dryness, and irritation, raising questions about the overall safety of smart contact lenses. Moreover, the risk of infections, stemming from factors such as inadequate lens hygiene or compromised seals, amplifies these concerns. The delicate nature of the eyes requires meticulous attention to safety standards.
The COVID-19 pandemic has had a mixed impact on the market. While the increased focus on remote health monitoring has spurred interest in wearable technologies, the economic uncertainties and disrupted supply chains have posed challenges. Delayed research and development, coupled with changes in consumer priorities, have influenced market dynamics. However, the growing awareness of health monitoring and the gradual recovery from the pandemic are expected to contribute to the market's resurgence as people seek innovative solutions for continuous healthcare in the post-COVID-19 era.
The diagnostic sensor integrated contact lens is expected to be the largest during the forecast period
The diagnostic sensor integrated contact lens segment is expected to have a lucrative growth. These lenses incorporate advanced diagnostic sensors capable of monitoring various health metrics, such as glucose levels or intraocular pressure. The real-time data collected by these sensors provides valuable insights for both users and healthcare professionals, allowing for continuous health monitoring. This targeted functionality enhances the diagnostic and preventive aspects of smart contact lenses, making them a crucial component in the evolution of healthcare technology and personalized patient care.
The Poly (2-Hydroxyethyl Methacrylate) (PHEMA) segment is expected to have the highest CAGR during the forecast period
The Poly (2-Hydroxyethyl Methacrylate) (PHEMA) segment is anticipated to witness the fastest CAGR growth during the forecast period. PHEMA is a hydrogel that is known for its biocompatibility, optical clarity, and water absorption properties, making it suitable for extended wear. It provides a comfortable and breathable platform for integrating various technologies, such as sensors and electronics, into contact lenses. This material's characteristics make it a popular choice for developing smart contact lenses, allowing for continuous and comfortable wear while supporting advanced functionalities for health monitoring and augmented reality applications.
During the forecast period, it is expected that the North American Smart Contact Lenses market will continue to hold a majority of the market share. The region's advanced healthcare infrastructure, coupled with a high level of technological adoption, contributes to the widespread acceptance of smart contact lenses. Increasing awareness of health monitoring and the presence of key market players and research institutions position North America at the forefront of smart contact lens development. The market in this region is characterized by a dynamic landscape, marked by continuous advancements and a growing emphasis on personalized healthcare solutions.
The Asia Pacific region is witnessing rapid growth in market. Factors such as a burgeoning population, increasing healthcare awareness, and rising demand for innovative wearables contribute to the market's expansion. Countries like Japan and South Korea are at the forefront of technological advancements, fostering a conducive environment for smart contact lens development. With a focus on healthcare innovation and improving the quality of life, the Asia Pacific Smart Contact Lenses Market is poised for significant development and market penetration.
Some of the key players in Smart Contact Lenses market include Alcon Vision LLC, Samsung, Google, Sony, Innovega Inc., Liner Technologies, Sensimed AG, Mojo Vision Inc. and Nuravision.
In October 2023, XPANCEO (UAE), a deep tech startup, has raised $40 million in seed funding to develop the first contact lenses with AR vision capabilities. Opportunity Ventures (Asia) of Hong Kong led the round. The funds will be used to launch the next prototype, which will combine several features into a single device.
In September 2022, Johnson & Johnson Vision (US) Introduced New Contact Lens Technology to Meet the Demands of Digitally Intense Lifestyles: ACUVUE® is a brand of presbyopia contact lenses. Developed with an unprecedented combination of new technologies to assist in meeting the needs of digitally intensive lifestyles